Are There Any Ongoing Studies Involving Romidepsin?
Yes, there are numerous ongoing clinical trials investigating the efficacy and safety of romidepsin in combination with other therapies. These studies aim to expand its use to other types of cancer and to improve outcomes for patients with T-cell lymphomas. Researchers are also exploring biomarkers that can predict response to romidepsin.
